Detalles de la búsqueda
1.
Ticagrelor with or without Aspirin in High-Risk Patients after PCI.
N Engl J Med
; 381(21): 2032-2042, 2019 11 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31556978
2.
Collagenase to facilitate guidewire crossing in chronic total occlusion PCI-The Total Occlusion Study in Coronary Arteries-5 (TOSCA-5) trial.
Catheter Cardiovasc Interv
; 99(4): 1065-1073, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35077606
3.
Ticagrelor monotherapy in patients at high bleeding risk undergoing percutaneous coronary intervention: TWILIGHT-HBR.
Eur Heart J
; 42(45): 4624-4634, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34662382
4.
Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
Eur Heart J
; 42(45): 4683-4693, 2021 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34423374
5.
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS.
Eur Heart J
; 41(37): 3533-3545, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33085967
6.
Impact of high on-treatment platelet reactivity on outcomes following PCI in patients on hemodialysis: An ADAPT-DES substudy.
Catheter Cardiovasc Interv
; 96(4): 793-801, 2020 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31721430
7.
Adverse events in patients with high platelet reactivity following successful chronic total occlusion PCI: The Assessment of Dual AntiPlatelet Therapy with Drug-Eluting Stents (ADAPT-DES) study.
Am Heart J
; 211: 68-76, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30897527
8.
The management of cardiac implantable electronic device lead perforations: a multicentre study.
Europace
; 21(6): 937-943, 2019 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31157389
9.
Percutaneous coronary intervention of lesions with in-stent restenosis: A report from the ADAPT-DES study.
Am Heart J
; 197: 142-149, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29447774
10.
Impact of high on-aspirin platelet reactivity on outcomes following successful percutaneous coronary intervention with drug-eluting stents.
Am Heart J
; 205: 77-86, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30196181
11.
Impact and trends of intravascular imaging in diagnostic coronary angiography and percutaneous coronary intervention in inpatients in the United States.
Catheter Cardiovasc Interv
; 92(6): E410-E415, 2018 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30019831
12.
Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization: Results From the Ranolazine for Incomplete Vessel Revascularization (RIVER-PCI) Trial.
Circulation
; 133(1): 39-47, 2016 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-26555329
13.
Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
Lancet
; 387(10014): 136-45, 2016 Jan 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-26474810
14.
Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES study.
Catheter Cardiovasc Interv
; 89(1): 26-35, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26813732
15.
Relationship between intravascular ultrasound guidance and clinical outcomes after drug-eluting stents: the assessment of dual antiplatelet therapy with drug-eluting stents (ADAPT-DES) study.
Circulation
; 129(4): 463-70, 2014 Jan 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-24281330
16.
Longitudinal Geographic Miss (LGM) in Robotic Assisted Versus Manual Percutaneous Coronary Interventions.
J Interv Cardiol
; 28(5): 449-55, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26489972
17.
Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy.
Eur Heart J
; 35(23): 1533-40, 2014 Jun 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-24603308
18.
Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study.
Lancet
; 382(9892): 614-23, 2013 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-23890998
19.
Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.
Lancet
; 382(9906): 1714-22, 2013 Nov 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-24004642
20.
Safety and efficacy of drug-eluting stents in women: a patient-level pooled analysis of randomised trials.
Lancet
; 382(9908): 1879-88, 2013 Dec 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-24007976